Guler, E. Et Al. 2023. Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance.. International journal of pharmaceutics , vol.635 , 122716.

Guler, E., Nur Hazar-Yavuz, A., TATAR, E., Morid Haidari, M., Sinemcan Ozcan, G., DURUKSU, G., ... Graça, M. P. F.(2023). Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance.. International journal of pharmaceutics , vol.635, 122716.

Guler, Ece Et Al. "Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance.," International journal of pharmaceutics , vol.635, 122716, 2023

Guler, Ece Et Al. "Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance.." International journal of pharmaceutics , vol.635, pp.122716, 2023

Guler, E. Et Al. (2023) . "Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance.." International journal of pharmaceutics , vol.635, p.122716.

@article{article, author={Ece Guler Et Al. }, title={Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance.}, journal={International journal of pharmaceutics}, year=2023, pages={122716} }